Cargando…

Colistin monotherapy versus combination of colistin with a β-lactam or rifampicin for the treatment of serious infections in the ICU due to multidrug-resistant Gram-negative bacteria

Detalles Bibliográficos
Autores principales: Tsimogianni, A, Frantzeskaki, F, Adamidis, V, Betrosian, A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2006
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4092477/
http://dx.doi.org/10.1186/cc4449
_version_ 1782325512116371456
author Tsimogianni, A
Frantzeskaki, F
Adamidis, V
Betrosian, A
author_facet Tsimogianni, A
Frantzeskaki, F
Adamidis, V
Betrosian, A
author_sort Tsimogianni, A
collection PubMed
description
format Online
Article
Text
id pubmed-4092477
institution National Center for Biotechnology Information
language English
publishDate 2006
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-40924772014-09-23 Colistin monotherapy versus combination of colistin with a β-lactam or rifampicin for the treatment of serious infections in the ICU due to multidrug-resistant Gram-negative bacteria Tsimogianni, A Frantzeskaki, F Adamidis, V Betrosian, A Crit Care Poster Presentation BioMed Central 2006 2006-03-21 /pmc/articles/PMC4092477/ http://dx.doi.org/10.1186/cc4449 Text en Copyright © 2006 BioMed Central Ltd
spellingShingle Poster Presentation
Tsimogianni, A
Frantzeskaki, F
Adamidis, V
Betrosian, A
Colistin monotherapy versus combination of colistin with a β-lactam or rifampicin for the treatment of serious infections in the ICU due to multidrug-resistant Gram-negative bacteria
title Colistin monotherapy versus combination of colistin with a β-lactam or rifampicin for the treatment of serious infections in the ICU due to multidrug-resistant Gram-negative bacteria
title_full Colistin monotherapy versus combination of colistin with a β-lactam or rifampicin for the treatment of serious infections in the ICU due to multidrug-resistant Gram-negative bacteria
title_fullStr Colistin monotherapy versus combination of colistin with a β-lactam or rifampicin for the treatment of serious infections in the ICU due to multidrug-resistant Gram-negative bacteria
title_full_unstemmed Colistin monotherapy versus combination of colistin with a β-lactam or rifampicin for the treatment of serious infections in the ICU due to multidrug-resistant Gram-negative bacteria
title_short Colistin monotherapy versus combination of colistin with a β-lactam or rifampicin for the treatment of serious infections in the ICU due to multidrug-resistant Gram-negative bacteria
title_sort colistin monotherapy versus combination of colistin with a β-lactam or rifampicin for the treatment of serious infections in the icu due to multidrug-resistant gram-negative bacteria
topic Poster Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4092477/
http://dx.doi.org/10.1186/cc4449
work_keys_str_mv AT tsimogiannia colistinmonotherapyversuscombinationofcolistinwithablactamorrifampicinforthetreatmentofseriousinfectionsintheicuduetomultidrugresistantgramnegativebacteria
AT frantzeskakif colistinmonotherapyversuscombinationofcolistinwithablactamorrifampicinforthetreatmentofseriousinfectionsintheicuduetomultidrugresistantgramnegativebacteria
AT adamidisv colistinmonotherapyversuscombinationofcolistinwithablactamorrifampicinforthetreatmentofseriousinfectionsintheicuduetomultidrugresistantgramnegativebacteria
AT betrosiana colistinmonotherapyversuscombinationofcolistinwithablactamorrifampicinforthetreatmentofseriousinfectionsintheicuduetomultidrugresistantgramnegativebacteria